$BGNE: BeiGene reports clinical data on Tislelizumab https://t.co/f1bfcfhxoh
The output is 2, which means the tweet conveys a positive emotion, because the company's stock, BeiGene ($BGNE), had positive news and reports about their clinical data on Tislelizumab. This is good news